Skip to main content

Day: August 12, 2024

ParaZero Received Order from a Leading Tier-One Defense Company for 50 Drone Safety Systems for Military Operational Use

Tel Aviv, Israel, Aug. 12, 2024 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “Company” or “ParaZero”), an aerospace company focused on drone safety systems for defense and commercial drones and urban air mobility aircraft, announced today a partnership with a Tier 1 leading defense OEM company to adapt and integrate its cutting-edge drone safety system for operational military and medical missions use. The Company received the first order as part of a wider collaboration that aims to enhance the efficiency and safety of medical field mission’s deliveries, particularly in critical and remote areas. In the initial phase, ParaZero will provide 50 systems to the customer for a testing phase, during which time ParaZero will develop and validate the necessary adaptations for the medical delivery system. Upon...

Continue reading

Sernova Corp. Announces Appointment of New Chief Executive Officer

LONDON, Ontario and BOSTON, Aug. 12, 2024 (GLOBE NEWSWIRE) — August 12, 2024. Sernova Corp. (“Sernova” or the “Company”) (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment of chronic diseases, led by an ongoing phase 1/2a clinical trial in type 1 diabetes, is pleased to announce Mr. Jonathan Rigby as the Company’s new Chief Executive Officer. James Parsons, on behalf of the Board of Directors of Sernova, stated, “The Board believes that Sernova is now positioned to achieve its strategic milestones under Jonathan’s leadership. Jonathan brings a track record of success raising equity capital for biotech companies. Jonathan has led multiple biotech companies through listings onto Nasdaq, and the achievement of key operational...

Continue reading

Trailbreaker Expands Watchtower Zone Gold Anomaly to 350m x 200m Along a 3km Gold Trend at Castle Rock Property

VANCOUVER, British Columbia, Aug. 12, 2024 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) is pleased to announce that recent surface sampling at the Watchtower zone has outlined a continuous gold (Au)-in-soil anomaly covering a 350 m by 200 m area. The zone trends northwest-southeast along a more extensive 3 km long gold-in-soil trend. Rock sampling from this zone returned assay values up to 2.19 g/t Au, 0.54% copper (Cu), and 6.2 g/t silver (Ag) from an outcrop with a ‘wormy’ quartz vein stockwork. The ‘wormy’ vein texture indicates a ductile deformational environment, with emplacement of quartz veining under high-temperature conditions, potentially in proximity to an intrusive body. Surface sampling was conducted at the Castle Rock property, northern Vancouver Island, British Columbia...

Continue reading

Allot to Release Second Quarter 2024 Earnings and Host Conference Call on August 27, 2024

Hod Hasharon, Israel, Aug. 12, 2024 (GLOBE NEWSWIRE) — Allot Ltd. (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security-as-a-service (SECaaS) solutions for communication service providers (CSPs) and enterprises, announced today that it will host a conference call to discuss its second quarter 2024 results on Tuesday, August 27, 2024 at 9:00AM ET (2:00PM UK, 4:00PM Israel). The unaudited financial results of the quarter will be published prior to the commencement of the conference call.‎ To access the conference call, please dial one of the following numbers: US:  1-888-642-5032, UK: 0-800-917-5108, Israel: +972-3-918-0610 A live webcast of the conference call can be accessed on the Allot website at http://investors.allot.com/. The webcast will also be archived on the website following...

Continue reading

Fortrea Reports Second Quarter 2024 Results

For the three months ended June 30, 2024, from continuing operations:Revenues of $662.4 million GAAP net loss of $(99.3) million Adjusted EBITDA of $55.2 million GAAP and adjusted diluted loss per share of $(1.11) and $(0.03), respectively Book-to-bill ratio of 0.96x, resulting in 1.16x book-to-bill for the trailing 12 months Completed divestiture of assets relating to the Endpoint Clinical and Patient Access businesses Debt paydown of $504 million in the quarter using initial divestiture and securitization proceeds Revised full-year guidanceDURHAM, N.C., Aug. 12, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (“CRO”), today reported financial results for the second quarter ended June 30, 2024. “Fortrea continues to make progress with customers and our business,...

Continue reading

Evaxion to Announce Business Update and Second Quarter 2024 Financial Results on August 14

COPENHAGEN, Denmark, Aug. 12, 2024 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2024 financial results on Wednesday, August 14, 2024, before opening of the Nasdaq-CM. Evaxion’s Executive Management will host a conference call and webcast the same day at 14:30 CEST/08:30 EDT presenting the update and results as well as taking questions. This event is free, open to the public and encouraged. To join the conference call, listen to the presentation and ask verbal questions, please register in advance via this link to receive the dial-in telephone numbers and a unique pin code. The call can be accessed 15 minutes prior to the start of the...

Continue reading

EHang to Report Second Quarter 2024 Unaudited Financial Results on Thursday, August 22, 2024

GUANGZHOU, China, Aug. 12, 2024 (GLOBE NEWSWIRE) — EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading urban air mobility (“UAM”) technology platform company, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2024 on Thursday, August 22, 2024, before the U.S. market opens. EHang’s management team will host an earnings conference call at 8:00 AM on Thursday, August 22, 2024, U.S. Eastern Time (8:00 PM on Thursday, August 22, 2024, Beijing/Hong Kong Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to...

Continue reading

Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge

MALVERN, Pa. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (“Neuronetics”) and Greenbrook TMS Inc. (OTCMKTS: GBNHF) (“Greenbrook”) today announced that they have entered into a definitive arrangement agreement (the “Definitive Agreement”) in which Neuronetics will acquire all of the outstanding common shares of Greenbrook in an all-stock transaction. “This transaction brings together two of the leaders in the mental health space in the U.S., which will allow us to provide access to innovative care to patients suffering from mental health conditions. Leveraging the significant scale and capabilities of the two businesses, we can drive increased awareness of NeuroStar, consistently deliver best practices, facilitate improved reimbursement on a regional and national level, and provide additional services...

Continue reading

Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results

MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”) a commercial stage medical technology company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the best neurohealth therapies in the world, today announced its financial and operating results for the second quarter of 2024. Second Quarter 2024 HighlightsSecond quarter 2024 revenue of $16.5 million, a 7% decrease as compared to the second quarter 2023 U.S. NeuroStar Advanced Therapy system revenue of $4 million in the quarter, representing 50 systems U.S. treatment session revenue decreased by 5% versus the second quarter of 2023Recent Operational and Marketing HighlightsAnnounces signing of definitive agreement to acquire all the outstanding shares of Greenbrook...

Continue reading

Form 8.3 – [KEYWORDS STUDIOS PLC – 09 08 2024] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.